{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04629729",
            "orgStudyIdInfo": {
                "id": "FT819-101"
            },
            "organization": {
                "fullName": "Fate Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "FT819 in Subjects With B-cell Malignancies",
            "officialTitle": "A Phase I Study of FT819 in Subjects With B-cell Malignancies",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "in-subjects-with-b-cell-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-07-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2039-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-10",
            "studyFirstSubmitQcDate": "2020-11-10",
            "studyFirstPostDateStruct": {
                "date": "2020-11-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-01",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Fate Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase I dose-finding study of FT819 as monotherapy and in combination with IL-2 in subjects with relapsed/refractory B-cell Lymphoma, Chronic Lymphocytic Leukemia and Precursor B-cell Acute Lymphoblastic Leukemia. The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts."
        },
        "conditionsModule": {
            "conditions": [
                "Lymphoma, B-Cell",
                "Chronic Lymphocytic Leukemia",
                "Precursor B-Cell Acute Lymphoblastic Leukemia"
            ],
            "keywords": [
                "Lymphoma",
                "Leukemia",
                "BCL",
                "CLL",
                "B-ALL",
                "CAR-T",
                "cellular therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 396,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "FT819 Single-Dose Monotherapy, B-Cell Lymphoma",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose monotherapy in adult subjects with r/r B-cell Lymphoma",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose in combination with IL-2 in adult subjects with r/r B-cell Lymphoma",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy, B-Cell Lymphoma",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in adult subjects with r/r B-cell Lymphoma",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Single-Dose Monotherapy, CLL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose monotherapy in adult subjects with r/r CLL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Single-Dose in Combination with IL-2, CLL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose in combination with IL-2 in adult subjects with r/r CLL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy, CLL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in adult subjects with r/r CLL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Single-Dose Monotherapy, B-ALL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose monotherapy in adult subjects with r/r B-ALL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Single-Dose in Combination with IL-2, B-ALL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 single-dose in combination with IL-2 in adult subjects with r/r B-ALL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy, B-ALL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in adult subjects with r/r B-ALL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in combination with IL-2 in adult subjects with r/r B-cell Lymphoma",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in combination with IL-2 in adult subjects with r/r CLL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                    "type": "EXPERIMENTAL",
                    "description": "FT819 monotherapy administered as step-fractionated dosing in combination with IL-2 in adult subjects with r/r B-ALL",
                    "interventionNames": [
                        "Drug: FT819",
                        "Drug: Cyclophosphamide",
                        "Drug: Fludarabine",
                        "Drug: IL-2",
                        "Drug: Bendamustine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "FT819",
                    "description": "Experimental Interventional Therapy",
                    "armGroupLabels": [
                        "FT819 Single-Dose Monotherapy, B-ALL",
                        "FT819 Single-Dose Monotherapy, B-Cell Lymphoma",
                        "FT819 Single-Dose Monotherapy, CLL",
                        "FT819 Single-Dose in Combination with IL-2, B-ALL",
                        "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Single-Dose in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy, B-ALL",
                        "FT819 Step Fractionated Monotherapy, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy, CLL"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "Lympho-conditioning agent",
                    "armGroupLabels": [
                        "FT819 Single-Dose Monotherapy, B-ALL",
                        "FT819 Single-Dose Monotherapy, B-Cell Lymphoma",
                        "FT819 Single-Dose Monotherapy, CLL",
                        "FT819 Single-Dose in Combination with IL-2, B-ALL",
                        "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Single-Dose in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy, B-ALL",
                        "FT819 Step Fractionated Monotherapy, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy, CLL"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine",
                    "description": "Lympho-conditioning agent",
                    "armGroupLabels": [
                        "FT819 Single-Dose Monotherapy, B-ALL",
                        "FT819 Single-Dose Monotherapy, B-Cell Lymphoma",
                        "FT819 Single-Dose Monotherapy, CLL",
                        "FT819 Single-Dose in Combination with IL-2, B-ALL",
                        "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Single-Dose in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy, B-ALL",
                        "FT819 Step Fractionated Monotherapy, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy, CLL"
                    ],
                    "otherNames": [
                        "Fludara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "IL-2",
                    "description": "Biologic response modifier",
                    "armGroupLabels": [
                        "FT819 Single-Dose in Combination with IL-2, B-ALL",
                        "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Single-Dose in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL"
                    ],
                    "otherNames": [
                        "Interleukin-2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bendamustine",
                    "description": "Lympho-conditioning agent",
                    "armGroupLabels": [
                        "FT819 Single-Dose Monotherapy, B-ALL",
                        "FT819 Single-Dose Monotherapy, B-Cell Lymphoma",
                        "FT819 Single-Dose Monotherapy, CLL",
                        "FT819 Single-Dose in Combination with IL-2, B-ALL",
                        "FT819 Single-Dose in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Single-Dose in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-ALL",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy in Combination with IL-2, CLL",
                        "FT819 Step Fractionated Monotherapy, B-ALL",
                        "FT819 Step Fractionated Monotherapy, B-Cell Lymphoma",
                        "FT819 Step Fractionated Monotherapy, CLL"
                    ],
                    "otherNames": [
                        "Bendeka",
                        "Treanda"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence and nature of dose-limiting toxicities within each dose level cohort",
                    "timeFrame": "Up to Day 29"
                },
                {
                    "measure": "Incidence, nature, and severity of adverse events (AEs) of FT819 as monotherapy and in combination with IL-2 in r/r B-cell lymphoma, r/r chronic lymphocytic leukemia, and r/r precursor B-cell acute lymphoblastic leukemia",
                    "timeFrame": "Up to 15 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Investigator-assessed objective-response rate (ORR)",
                    "timeFrame": "Up to approximately 2 years after last dose of FT819"
                },
                {
                    "measure": "For BCL and CLL Only: Investigator-assessed duration of objective response (DOR)",
                    "timeFrame": "Up to 15 years"
                },
                {
                    "measure": "For BCL and CLL Only: Investigator-assessed duration of complete response (DoCR)",
                    "timeFrame": "Up to 15 years"
                },
                {
                    "measure": "For BCL and CLL Only: Progression-free survival (PFS)",
                    "timeFrame": "Up to 15 years"
                },
                {
                    "measure": "Overall survival (OS)",
                    "timeFrame": "Up to 15 years"
                },
                {
                    "measure": "Determination of the pharmacokinetics of FT819 cells in peripheral blood.",
                    "description": "The PK of FT819 in peripheral blood will be reported as the relative percentage of product (FT819) DNA versus patient DNA (% chimerism) measured from blood samples at the specified time points",
                    "timeFrame": "Study Days 1, 2, 3, 4, 5, 8, 11, 15, 22, and 29"
                },
                {
                    "measure": "For B-ALL Only: Investigator-assessed relapse-free survival (RFS)",
                    "timeFrame": "Up to 15 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\nDiagnosis of B-cell lymphoma, CLL or B-ALL as described below:\n\nB-Cell Lymphoma:\n\n* Histologically documented lymphomas expected to express CD19\n* Relapsed/refractory disease following at least 2 prior lines of multi-agent immunochemotherapy\n\nChronic Lymphocytic Leukemia (CLL):\n\n* Diagnosis of CLL per iwCLL guidelines\n* Relapsed/refractory disease following at least two prior systemic treatment regimens\n\nPrecursor B-cell Acute Lymphocytic Leukemia (B-ALL):\n\n* Diagnosis of B-ALL by flow cytometry, bone marrow histology, and/or cytogenetics\n* Relapsed/refractory disease after at least 2 cycles of standard multiagent induction chemotherapy. For subjects with Philadelphia-chromosome positive (Ph+) disease, failure or intolerance to a tyrosine kinase inhibitor therapy-containing regimen\n\nALL SUBJECTS:\n\n* Capable of giving signed informed consent\n* Age \u2265 18 years old\n* Stated willingness to comply with study procedures and duration\n* Contraceptive use for women and men as defined in the protocol\n\nKey Exclusion Criteria:\n\nALL SUBJECTS:\n\n* Females who are pregnant or breastfeeding\n* Eastern Cooperative Oncology Group (ECOG) Performance Status \u22652\n* Body weight \\<50 kg\n* Evidence of insufficient organ function\n* Receipt of therapy within 2 weeks prior to Day 1 or five half-lives, whichever is shorter; or any investigational therapy within 28 days prior to Day 1\n* Currently receiving or likely to require systemic immunosuppressive therapy\n* Ongoing requirement for systemic GvHD therapy following prior allogeneic hematopoietic stem cell transplant (HSCT) or allogeneic CAR-T\n* Receipt of an allograft organ transplant\n* Known active central nervous system (CNS) involvement by malignancy\n* Non-malignant CNS disease such as stroke, epilepsy, CNS vasculitis, or neurodegenerative disease\n* Clinically significant cardiovascular disease\n* Positive serologic test results for HIV infection\n* Positive serologic and polymerase chain reaction (PCR) test results for Hepatitis B (HBV) infection\n* Positive serologic and PCR test results for Hepatitis C (HCV) infection\n* Live vaccine \\<6 weeks prior to start of lympho-conditioning\n* Known allergy to albumin (human) or DMSO",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Fate Trial Disclosure",
                    "role": "CONTACT",
                    "phone": "866-875-1800",
                    "email": "FateTrialDisclosure@fatetherapeutics.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Fate Trial Disclosure",
                    "affiliation": "Fate Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Mayo Arizona",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85054",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Januario Castro",
                            "role": "CONTACT",
                            "phone": "480-301-8000",
                            "email": "castro.januario@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "UC Davis",
                    "status": "RECRUITING",
                    "city": "Davis",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joseph Tuscano, MD",
                            "role": "CONTACT",
                            "phone": "916-734-3772",
                            "email": "jtuscano@ucdavis.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.54491,
                        "lon": -121.74052
                    }
                },
                {
                    "facility": "UCLA Ronald Reagan Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Stanford Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Mayo Florida",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Madiha Iqbal, MBBS, MD",
                            "role": "CONTACT",
                            "phone": "904-953-2795",
                            "email": "Iqbal.Madiha@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "University of Iowa",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Norton Cancer Institute, St. Matthews Campus",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40207",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Mayo Minnesota",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Saad Kendarian",
                            "role": "CONTACT",
                            "phone": "507-284-2511",
                            "email": "Kendarian.Saad@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Oregon Health & Sciences University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "University of Wisconsin-Madison",
                    "status": "RECRUITING",
                    "city": "Madison",
                    "state": "Wisconsin",
                    "zip": "53705",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.07305,
                        "lon": -89.40123
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "AACR 2020 Poster # 3245",
                    "url": "https://cancerres.aacrjournals.org/content/80/16_Supplement/3245"
                },
                {
                    "label": "ASH 2022 Poster Presentation",
                    "url": "https://fatetherapeutics.com/wp-content/uploads/2022/12/2000-FT81989.pdf"
                },
                {
                    "label": "ASH 2022 Abstract",
                    "url": "https://ash.confex.com/ash/2022/webprogram/Paper167194.html"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000054198",
                    "term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
                },
                {
                    "id": "D000015451",
                    "term": "Leukemia, Lymphocytic, Chronic, B-Cell"
                },
                {
                    "id": "D000016393",
                    "term": "Lymphoma, B-Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000015448",
                    "term": "Leukemia, B-Cell"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M18116",
                    "name": "Leukemia, Lymphocytic, Chronic, B-Cell",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "asFound": "Lymphoma, B-Cell",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27585",
                    "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18115",
                    "name": "Leukemia, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1308",
                    "name": "Chronic Lymphocytic Leukemia",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "Lymphoma, B-Cell",
                    "relevance": "HIGH"
                },
                {
                    "id": "T175",
                    "name": "Acute Lymphoblastic Leukemia",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3533",
                    "name": "Lymphoblastic Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000069461",
                    "term": "Bendamustine Hydrochloride"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "D000007376",
                    "term": "Interleukin-2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M430",
                    "name": "Bendamustine Hydrochloride",
                    "asFound": "Inserted",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10411",
                    "name": "Interleukin-2",
                    "asFound": "Reconstruction",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                }
            ]
        }
    },
    "hasResults": false
}